관상동맥 스텐트 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Coronary Stents Market was valued at USD 7.5 billion in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2034. This growth is driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in stent technologies, and a growing preference for minimally invasive treatments. In addition, the aging population and rising health concerns contribute significantly to market expansion.

Coronary stents are vital devices used to maintain blood flow by keeping narrowed or blocked arteries open, playing a crucial role in managing coronary artery disease (CAD). The growing demand for these devices stems from unhealthy lifestyles, aging populations, and the rising incidence of cardiovascular conditions. Innovative developments like bioresorbable scaffolds, drug-eluting stents (DES), and polymer-free stents are enhancing treatment outcomes by reducing risks associated with artery re-narrowing and blood clots.

The market is segmented by product into bioresorbable vascular scaffolds (BVS), drug-eluting stents, and bare-metal stents. Drug-eluting stents dominated the market in 2024, generating significant revenue due to their superior ability to prevent restenosis. These stents release medication to inhibit tissue growth, reducing the need for repeat procedures and improving long-term patient outcomes.

In terms of type, the market includes balloon-expandable and self-expandable stents. Balloon-expandable stents captured the largest market share in 2024, accounting for 58.3%. Their precision and control during deployment make them highly effective for treating complex or narrow artery cases. These stents are particularly beneficial for addressing calcified lesions and hardened plaque, further enhancing their adoption.

By material, the market is segmented into cobalt-chromium alloy, stainless steel, and others. Stents made of cobalt-chromium alloy held the leading position in 2024 and are expected to reach USD 7.6 billion by the end of the forecast period. This material offers exceptional strength and durability, allowing for thinner, more effective designs that reduce artery injuries and improve blood flow.

End-use segmentation highlights cardiac centers, hospitals, and ambulatory surgical centers, with cardiac centers leading the market in 2024. These facilities offer advanced technologies and specialized expertise, ensuring high-quality care for complex cardiac procedures.

North America led the market in 2024, with revenues of USD 3 billion. A robust healthcare system, widespread access to advanced cardiac care, and high rates of cardiovascular disease support the region's strong market position.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising burden of coronary artery disease
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Technological advancement in developing economies
    • 3.2.1.4 Increasing awareness and focus on preventive cardiac care
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Product failure and recall
    • 3.2.2.2 Stringent regulatory approvals
    • 3.2.2.3 Dearth of skilled healthcare professional in developing economies
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Future market trends
• 3.6 Regulatory landscape
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Pricing analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Drug-eluting stent
• 5.3 Bioresorbable vascular scaffold (BVS)
• 5.4 Bare metal stent

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Balloon expendable stent
• 6.3 Self-expendable stent

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Cobalt-chromium alloy
• 7.3 Stainless steel
• 7.4 Other materials

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Cardiac centers
• 8.3 Hospitals
• 8.4 Ambulatory surgical centers
• 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Abbott Laboratories
• 10.2 Andramed GmbH
• 10.3 B. Braun Melsungen
• 10.4 Biosensors International Group
• 10.5 Biotronik SE & Co. KG
• 10.6 Boston Scientific Corporation
• 10.7 Cook Medical
• 10.8 Elixir Medical Corporation
• 10.9 GENOSS
• 10.10 Medtronic
• 10.11 Meril Life Science
• 10.12 MicroPort Scientific Corporation
• 10.13 Sahajanand Laser Technology
• 10.14 Stryker Corporation
• 10.15 Terumo Corporation